PharmaBoardroom

Arnaud de Rincquesen - Managing Partner, Deloitte: Companies are willing to come to Algeria. It’s an interesting market. What matters once again is…

PharmaBoardroom recently conducted a roundtable event with the key opinion leaders of Algeria’s healthcare sector. This is a sample of the…

Lygature is the new name of TI Pharma and CTMM, two internationally renowned public-private-partnerships turned non-for-profit partnership drivers.…

The Director of the newly formed Necker Institute for Sick Children reveals how the inspiration behind INEM was to bring people together in order to…

José M. Jiménez, Vice President and General Manager of Torcon Puerto Rico, outlines current construction projects within the life science and…

The Centre for Human Drug Research provides a full range of early stage clinical pharmacology services. The CEO discusses the vision behind the…

The CEO of IPASA reveals how over the last ten months the priority has been to reach out to different stakeholders, rebuilding trust with the…

Pfizer Global Established Products’ BU Head and Hospira’s Director of Institutional Affairs tell us about Pfizer’s recent major acquisition…

The Head of the Department of Medical Oncology at the Pitié-Salpêtrière Hospital reveals how France is the only country in the world with universal…

The Head of Corporate & Institutional Banking of the Mauritius Commercial Bank explains why the diversification of the Mauritian economy into the…

Tugce Gozacan (pictured) and Okan Gozacan, Owner and Chairman of Marmara Ecza respectively, discuss what qualities are crucial for suppliers in the…

The general manager of Drogsan, Ersan Kuçuk elaborates on the company’s efforts in shifting towards more value-added pharmaceutical products,…